TrialJournal of neurology2017

Peginterferon beta-1a reduces the evolution of MRI lesions to black holes in patients with RRMS: a post hoc analysis from the ADVANCE study.

Douglas L Arnold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.